Press Releases

MellingMedical announced today a new strategic relationship with Zynex Medical, an industry pioneer in non-invasive medical devices for pain management and rehabilitation. The collaboration leverages MellingMedical's status as an SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB) to bring Zynex's innovative pain management solutions to federal healthcare providers serving America's military personnel, DoD and veterans. "While we offer a wide range o

GE HealthCare today announced that the U.S. Food and Drug Administration (FDA) has approved an updated label for its positron emission tomography (PET) imaging agent VizamylTM (flutemetamol F 18 injection) for beta-amyloid detection. The revised label, effective immediately, expands the indications for use, enables quantitative analysis of Vizamyl scans, and removes significant previous limitations such as monitoring patient response to anti-amyloid therapy. Up to now, amyloid

Exactech, a global medical device technology leader, announced the first surgery using the new Alteon® Short Tapered Wedge Hip Stem. The procedure was performed by Mark Schinsky, MD, with The American Hip Institute & Orthopedic Specialists in Chicago. For every total hip replacement, my goal as a surgeon is to reconstruct a mechanically stable hip joint with implants that fit the patient's anatomical needs," said Dr. Schinsky. "The Alteon Short Tapere

Ancora Heart, Inc., a medical device company developing a transcatheter device-based therapy to address heart failure (HF), today announced that it has reached the first enrollment milestone in the CORCINCH-HF pivotal trial evaluating the AccuCinch® Transcatheter Left Ventricular Restoration System in patients with heart failure with reduced ejection fraction (HFrEF). Six-month follow-up data on these 250 patients will support the company’s Premarket Approval (PMA) submission to the

Building on a collaboration that spans more than three decades, GE HealthCare has renewed its research collaboration with Stanford Medicine – with one of their key intentions being the development and research of innovative total body PET/CT technology.i This effort is expected to explore new clinical pathways and help enhance patient outcomes through innovative imaging solutions. “PET/CT has revolutionized the way we understand and treat disease by allowing us to visual

CereVasc, Inc., a clinical-stage medical device company developing novel treatments for neurological diseases, announced today that it has received Investigational Testing Authorization (ITA) from Health Canada to conduct the STRIDE trial, a clinical study evaluating CereVasc's eShunt System as a treatment for normal pressure hydrocephalus (NPH). The trial will evaluate the safety and effectiveness of the eShunt System versus the current standard of care, the ventriculo-peritone

Smith+Nephew the global medical technology company, today announces a strategic partnership with Standard Health www.standardhealth.co.uk to support the development of the first-ever Orthopaedic Ambulatory Surgery Centre in the UK. Based in Poole, Dorset, the new centre will offer NHS and private patients access to leading joint repair and replacement technology for conditions such as rotator cuff repair, ACL reconstruction, knee and hip replacements, and foot & ankle/hand & wris

Medtronic, a global leader in healthcare technology, and IRCAD North America, the new North American headquarters of globally recognized surgical education, innovation, and research institute, IRCAD, today announced a strategic collaboration. As a strategic partner, Medtronic will integrate its technologies at IRCAD North America, a non-profit subsidiary of Atrium Health, to build world-class training and education experiences for surgeons and medical professionals in cardiovascular

Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, today announced the successful closure of a $55 million funding round from the company’s existing investment syndicate of Third Rock Ventures, General Catalyst Partners, AccelMed, Lumira Ventures, and two strategic investors. The funds will be used to complete the ongoing RESPONDER-HF trial, a double-blinded, randomized, sham-controlled, confirmatory trial of the Corvia® Atrial Shunt c

SS Innovations International, Inc. a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the first robotic cardiac surgery in the Americas and Western Hemisphere has been successfully performed utilizing the Company’s SSi Mantra 3 surgical robotic system. On June 8, 2025, Dr. Juan Zuniga, a cardiothoracic surgeon from Interhospital in Guayaquil, Ecuador, became the first sur